Canadian Real-Life Evaluation of the Effectiveness of Lupron in the Management of Prostate Cancer (CRONOS)
Phase of Trial: Phase IV
Latest Information Update: 09 Apr 2018
At a glance
- Drugs Leuprorelin (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms CRONOS
- Sponsors Abbott Laboratories; AbbVie
- 10 Jun 2017 Biomarkers information updated
- 22 Sep 2016 Status changed from active, no longer recruiting to completed.
- 15 Jul 2016 Planned End Date changed from 1 Jul 2016 to 1 Sep 2016.